Effect of amiodarone versus placebo in 1202 postmyocardial infarction patients with ventricular ectopy in the CAMIAT trial. By an intention to treat analysis, amiodarone produced a significant reduction in arrhythmic death (top panel, p = 0.016) but no change in all-cause mortality (bottom panel).
Data from: Cairns JA, Connolly SJ, Gent M, et al. Lancet 1997; 349:675.
